Med-Surg

Key takeaways

• In the 149 hospitalizations with a demonstrable creatinine change, 33 cases (22.1%) were undocumented.
• Higher maximal creatinine was associated with lower adjusted odds of underdocumentation.
• The study did not test whether a detection or documentation intervention improves care or outcomes.

Nursing implications

• Trend ordered renal-function results and communicate clinically important changes through the care team according to local escalation and documentation workflows.

Limitations & cautions

• Abstract-only summary. This was a retrospective, single-center study of 161 hospitalizations; urine-output criteria and reliable preadmission creatinine values were unavailable, and the reference creatinine method may affect case classification.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• At baseline, 87% of participants had a 25-hydroxyvitamin D level of 40 ng/mL or lower.
• The primary composite outcome and the individual outcomes of death, heart-failure hospitalization, and stroke were not significantly different.
• A lower recurrent-MI rate was a secondary finding and should not override the nonsignificant primary result.

Nursing implications

• Reinforce the prescribed secondary-prevention plan and avoid implying that vitamin D replaces therapies with established post-MI benefit.

Limitations & cautions

• Abstract-only summary. The trial included 630 participants, 78.1% were men, the primary confidence interval included benefit and no benefit, and individual secondary outcomes were not the primary endpoint.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• SARS-CoV-2, influenza A, rhinovirus or enterovirus, and RSV were the most frequently identified viruses.
• hMPV and RSV tended to have higher odds of moderate or severe disease.
• Virus-specific patterns were associations from a cohort, not randomized comparisons.

Nursing implications

• During outbreaks or suspected infection, trend oxygen needs, mobility and time in bed, recovery, and signs of bacterial pneumonia according to facility protocols.

Limitations & cautions

• Abstract-only summary. Data came from 15 Dutch nursing homes, the overall suspected-infection risk estimate was imprecise, and virus-outcome comparisons may be affected by confounding and small subgroup counts.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• All participants first received conservative complex decongestive therapy for up to seven months.
• Quality-of-life secondary outcomes improved more with liposuction.
• The 12-month benefit was accompanied by a higher serious-adverse-event rate, and 36-month follow-up is ongoing.

Nursing implications

• For patients undergoing lipoedema surgery, follow ordered postoperative surveillance and escalate pain, bleeding, wound, or other recovery concerns through the care team.

Limitations & cautions

• Abstract-only summary. Participants were women treated at 11 German centers, long-term follow-up is ongoing, and the abstract does not identify the types of serious adverse events.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The between-group difference did not meet the prespecified 12-point target for clinical importance.
• Robotic-assisted replacement was more costly as delivered in routine practice.
• Sixteen participants in each group experienced one serious adverse event.

Nursing implications

• Use the same ordered postoperative assessment, mobility, pain, and complication-prevention pathway regardless of the instrument system used.

Limitations & cautions

• Abstract-only summary. Findings apply to the Mako system as delivered in this trial; 36-month follow-up is ongoing.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Combined therapy probably increased breast-cancer risk and may have increased stroke and venous-thromboembolism risk.
• Estrogen-only therapy probably increased stroke and gallbladder-surgery risk while reducing clinical fractures.
• Findings were driven largely by older oral regimens and may not represent hormone therapy used today.

Nursing implications

• Confirm the prescribed formulation and promptly communicate new thromboembolic, neurologic, or gallbladder symptoms through the care team.

Limitations & cautions

• Abstract-only summary. The review addressed therapy lasting at least one year, not short-term symptom relief. Most participants were older than the group most likely to seek treatment for vasomotor symptoms.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The document focuses on scenarios that are not well represented in antiarrhythmic-drug trials.
• Its practical advice combines the available evidence with multidisciplinary expert experience.
• The abstract does not support applying one antiarrhythmic approach across all understudied situations.

Nursing implications

• Verify the scenario-specific treatment and monitoring plan, then follow provider orders and local medication-safety protocols.

Limitations & cautions

• Abstract-only summary. The abstract does not enumerate individual recommendations, patient groups, drug choices, doses, or monitoring thresholds.
• AI-summarized from the linked source. Review the original statement before applying to practice.

Key takeaways

• ReacStep improved maximum step length and choice stepping reaction time compared with the control condition.
• The groups did not differ significantly in laboratory-assessed reactive-balance falls or daily-life falls.
• Adherence to ReacStep sessions was 90%, and the program was described as well tolerated.

Nursing implications

• Keep using the facility's multifactorial fall-prevention bundle; this trial does not support substituting ReacStep for established precautions.

Limitations & cautions

• Abstract-only summary. The trial included 88 participants, and the intervention did not improve the fall outcomes assessed over 12 months.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Metabolic and cardiovascular complications showed higher pooled risks.
• Results varied by complication type; not every outcome showed higher risk.
• Heterogeneity remained incompletely explained.

Nursing implications

• Include diabetes-related concerns in mental health handoffs and coordinate follow-up through the existing care plan.

Limitations & cautions

• Abstract-only summary. Associations do not establish causation or prove that a specific depression intervention reduces diabetes complications. Pooled relative risks are not individual risk predictions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Ambulatory blood pressure findings came from only two trials and had moderate certainty.
• Blood pressure response improved, but control-target achievement did not differ significantly.
• Evidence concerning major adverse events was very low certainty.

Nursing implications

• Interpret blood pressure trends in the context of the prescribed regimen; this review does not identify one best combination for every patient.

Limitations & cautions

• Abstract-only summary. Comparators varied, long-term data were limited, and Asian populations predominated. The review does not establish superior cardiovascular outcomes.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Target phosphorus achievement did not differ significantly between groups.
• Ferric citrate improved iron-related measures and hemoglobin.
• Most reported treatment-emergent adverse events were mild; gastrointestinal disorders were the most common.

Nursing implications

• When reviewing prescribed binder therapy, communicate phosphorus trends and gastrointestinal symptoms to the dialysis team.

Limitations & cautions

• Abstract-only summary. The study was open-label, lasted 12 weeks, and enrolled Chinese patients. It does not establish long-term safety or superiority for patient-centered outcomes.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Grade 3 or higher infection occurred in 28% versus 41%, respectively.
• Grade 3 or higher hemorrhage occurred in 2% versus 12%, respectively.

Nursing implications

• Reinforce the individualized oncology plan and communicate infection or bleeding concerns promptly.

Limitations & cautions

• Abstract-only summary of an industry-funded phase 2 trial. Core-binding-factor fusions, FLT3 mutations, and NPM1 mutations in patients under 60 were excluded. Event-free survival is not overall survival.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Four recommendations had moderate-certainty evidence; none had high-certainty inpatient-specific evidence.
• The guideline addresses medication initiation and selection, inpatient counseling, and post-discharge counseling.

Nursing implications

• Use the local tobacco-treatment pathway to offer support, respect a patient's decision to decline, and communicate the follow-up plan.

Limitations & cautions

• Abstract-only summary. Individual recommendation statements, drug choices, and dosing require the full guideline; certainty ranged from moderate to very low.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Drowsiness/somnolence was more frequent with duloxetine (risk ratio 1.88).
• Opioid-sparing estimates at 48-72 hours had extreme heterogeneity.

Nursing implications

• When duloxetine is prescribed, assess pain during rest and movement and document drowsiness rather than assuming less opioid use means better recovery.

Limitations & cautions

• Abstract-only summary. Substantial heterogeneity limits confidence; some apparent longer-term and adverse-effect benefits lost statistical significance after one high-risk trial was removed.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The study used a convenience sample of 54 adults at one Midwestern academic medical center.
• Each participant received a 15-pound weighted blanket and usual care in randomized order.
• During the first 20-minute period, mean self-rated anxiety was 3.6 points lower with the blanket.
• The trial supports short-term comfort use but does not establish longer-term benefit or broad suitability.

Nursing implications

• If weighted blankets are available under local policy, assess whether the patient wants one, can remove or reposition it, and has no clinical or device-related barrier to its use. Reassess comfort and anxiety rather than assuming the same response for every patient.

Limitations & cautions

• This was a small, single-center convenience sample with self-reported short-term outcomes. The back-to-back crossover periods and persistence after blanket removal may complicate interpretation, and the abstract does not establish longer-term effectiveness or safety in patients unable to reposition the blanket independently.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Fifteen randomized trials with 7,995 community-dwelling older adults were included.
• Evidence for institutionalization, hospital admissions, and mortality was very low certainty.
• Nurse-led case management probably produced a slight improvement in physical quality of life.
• The authors recommend evaluating patient-reported outcomes alongside healthcare utilization.

Nursing implications

• When participating in community case management, document the patient's own goals, function, quality of life, access barriers, and continuity needs in addition to emergency visits and admissions. Do not promise that coordination alone will prevent hospitalization or institutionalization.

Limitations & cautions

• Certainty was very low for the major utilization and mortality outcomes, and the physical quality-of-life improvement was small with uncertain clinical importance. Programs and populations varied, so the review does not identify one case-management model that should be adopted universally.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The multidisciplinary panel followed the American Academy of Neurology clinical-guideline process.
• Recommendations address when to start and how to choose preventive medication.
• The guideline considers comorbidities, older age, pregnancy and lactation, sex-related factors, and medication overuse.
• Treatment efficacy, adverse effects, and decisions about discontinuation are part of the recommended decision framework.

Nursing implications

• Reconcile acute and preventive migraine medicines, document headache frequency and functional burden, ask about overuse and adverse effects, and surface pregnancy, lactation, age, and relevant comorbidities to the prescribing team. Use the full guideline for drug-specific recommendations.

Limitations & cautions

• The PubMed abstract describes the guideline's scope but does not reproduce its individual recommendation statements, medication-specific cautions, or strength-of-recommendation ratings. This brief therefore does not identify a preferred drug or supply dosing guidance.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The randomized study enrolled 80 patients at two hospitals.
• Slow deep breathing was tested as an adjunct during chest-tube removal after CABG.
• Mean pain during removal was lower with breathing exercises than with standard care.
• Anxiety and post-removal pain were also lower, but the abstract does not provide every effect estimate.

Nursing implications

• Where the unit permits it, explain and rehearse slow deep breathing before removal, coach the patient through the procedure, and reassess pain and anxiety afterward. Treat it as an adjunct, not a replacement for prescribed analgesia or procedural monitoring.

Limitations & cautions

• The trial was small and conducted at two hospitals, with self-reported pain and anxiety. The abstract does not describe blinding, the exact breathing protocol, all effect sizes, analgesic use, or longer-term outcomes, limiting transfer to other settings.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included nine randomized placebo-controlled trials and 6,239 adults without diabetes.
• Mean percentage body-weight change favored semaglutide by 12.04 percentage points.
• Waist circumference and C-reactive protein also decreased relative to placebo.
• Serious adverse events did not differ significantly, but the review called for longer-term safety and efficacy data.

Nursing implications

• Confirm the product, prescribed dose and titration, indication, administration technique, missed-dose plan, tolerance, and follow-up. Report concerning symptoms or inability to maintain hydration and nutrition through the prescribing team's established pathway.

Limitations & cautions

• The abstract reports nine placebo-controlled trials but does not establish long-term outcomes across all clinical populations. The serious-adverse-event estimate was imprecise, and pooled efficacy should not be used to predict an individual's response or support an unprescribed dose change.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The study measured peak inspiratory flow in 273 clinically stable patients treated with a pMDI and spacer.
• At medium-high resistance, 96.0% reached at least 30 L/min and 61.9% reached at least 60 L/min.
• Lower inspiratory flow was associated with greater dyspnea and more severe airflow limitation in bivariate analyses.
• The findings support individualized assessment rather than assuming that spacer use reflects inadequate inspiratory capacity.

Nursing implications

• Ask the patient to demonstrate the prescribed inhaler and spacer, assess coordination and full exhalation, and document dyspnea and device barriers. If technique remains ineffective or the device is burdensome, request respiratory or prescribing-team review rather than switching devices independently.

Limitations & cautions

• This cross-sectional study involved clinically stable patients already using pMDIs with spacers and did not compare clinical outcomes after device changes. Thresholds depend on device resistance, and multiple authors reported industry relationships, including manuscript support from Orion.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Postextraction bleeding occurred after 33 of 271 procedures and 38 of 512 extracted teeth.
• First bleeding appeared at a mean 5.3 days and median six days after extraction.
• Extraction of four or more teeth was associated with higher procedure-level bleeding incidence.
• Tranexamic-acid use was associated with lower bleeding incidence, but retrospective confounding prevents a causal treatment conclusion.

Nursing implications

• At discharge, reconcile the procedure and prescribed factor or antifibrinolytic plan, confirm the patient can obtain and use ordered therapy, and use teach-back for local care, bleeding signs, and the exact escalation route during the following two weeks.

Limitations & cautions

• This retrospective four-center cohort had limited bleeding events and possible confounding by indication. Associations with tranexamic acid, primary wound closure, and number of extracted teeth do not prove that any one factor caused or prevented bleeding.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The statement fills gaps left by guidance focused on more common inherited arrhythmia syndromes.
• Recommendations integrate available evidence with expert opinion using European Society of Cardiology consensus methods.
• The framework covers pharmacologic therapy, left cardiac sympathetic denervation, and selective implantable-cardioverter-defibrillator use.
• Pediatric and fetal presentation, molecular autopsy, family screening, and multidisciplinary specialized care receive specific attention.

Nursing implications

• For a patient with a known or suspected inherited arrhythmia syndrome, reconcile the exact diagnosis, symptoms, rhythm history, medications, implanted-device status, family history, and specialist emergency plan. Escalate syncope, palpitations with instability, seizures of uncertain cause, or concerning rhythm change urgently.

Limitations & cautions

• These very rare conditions have limited prospective evidence, so the statement combines evidence with expert consensus. The PubMed abstract summarizes the framework but does not provide condition-specific recommendation classes, doses, or algorithms; readers should consult the full statement.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The meta-analysis included 15 articles and 1,617 patients with major depressive disorder.
• Depression and anxiety scale scores decreased after ECT across age groups.
• Adults older than 60 appeared to have a greater improvement in depressive symptoms in some analyses.
• High heterogeneity, varied ECT protocols, and limited age-stratified data reduce confidence in the age comparison.

Nursing implications

• Record baseline and serial mood, anxiety, orientation, cognition, and reported memory concerns using the service's protocol. Communicate clinically important change promptly and provide treatment education without promising a response based on age.

Limitations & cautions

• Only 15 articles were included, age-stratified data were limited, heterogeneity was high, and ECT frequency, intensity, co-treatments, and cognitive-assessment timing varied. These factors limit causal and age-specific interpretation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The prospective study included 9,697 eligible older ED patients, but only 3,039 underwent ISAR screening.
• Recent hospitalization within six months was associated with 3-day ED revisits and readmissions.
• The reported odds ratios were 1.852 for an ED revisit and 2.290 for readmission.
• The study supports risk flagging, not using one question as a substitute for clinical assessment or disposition planning.

Nursing implications

• Ask older patients or caregivers about hospital stays during the previous six months and verify the history when possible. If present, incorporate it into the full risk assessment and communicate unresolved symptoms, medication changes, support gaps, or follow-up barriers.

Limitations & cautions

• This was a single-community-hospital study in Taiwan, and fewer than one-third of eligible patients were screened. The observational association does not prove that recent hospitalization causes return visits or that acting on the item alone prevents them.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The intervention followed root-cause analysis and combined clinical discharge criteria with operational workflow changes.
• Mean boarded patients fell from 716.6 per month at baseline to 129.6 per month three months after implementation.
• Mean cumulative PACU length of stay fell from 745.3 to 215.5 hours per month.
• No increases were reported in postoperative adverse events, unplanned PACU readmissions, or escalation of care, but the study was not randomized.

Nursing implications

• Use standardized recovery and motor-block assessment, complete transfer documentation on time, and escalate bed or handoff barriers through the local flow pathway. Track balancing measures so faster movement does not come at the expense of recovery safety.

Limitations & cautions

• This was a pre-post quality-improvement study at one governmental hospital. Multiple changes occurred together, the abstract did not provide patient-level denominators or statistical comparisons, and three-month follow-up does not establish durability or generalizability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The score uses routinely available peri-intubation data to estimate ventilation beyond 48 hours.
• External-validation AUROCs ranged from 0.65 to 0.71, lower than several development and internal-validation estimates.
• The authors reported net benefit in decision-curve analyses, but no prospective impact on patient outcomes was tested.
• Ventilator settings in the model are predictors, not causal targets that should be changed to alter the score.

Nursing implications

• If the score is locally approved, enter peri-intubation data accurately and interpret the output alongside trajectory, diagnosis, frailty, ventilator response, and team assessment. Do not change ventilator settings to manipulate a prediction or use the score alone for treatment decisions.

Limitations & cautions

• The study was retrospective, discrimination was modest in external validation, and the model omitted potentially important factors such as diagnosis and frailty. Its clinical value and effect on patient outcomes have not been established prospectively.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The ISTH document covers factor-concentrate use for bleeding in cardiac surgery, trauma, obstetric care, and organ transplantation.
• It reviews fibrinogen concentrate, prothrombin complex concentrate, recombinant activated factor VII, and factor XIII concentrate.
• The guidance incorporates evidence published since the prior 2018 ISTH guidance and evolving bleeding-management practice.
• Its pragmatic guidance is based on the available evidence and expert consensus; the abstract does not support a single universal regimen.

Nursing implications

• Activate the approved major-bleeding pathway, communicate the surgical context and evolving blood loss, obtain ordered coagulation testing promptly, and verify the exact product, dose, route, and monitoring plan before administration. Track response and complications through the local protocol.

Limitations & cautions

• The accessible PubMed abstract describes the guidance scope but does not list agent-specific indications, contraindications, doses, evidence certainty, or recommendation strength. Those details require review of the full guidance, and expert consensus contributes where evidence is limited.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The consensus contains 39 statements covering assessment and stepwise management of chronic constipation.
• It emphasizes symptom severity, psychosocial impact, overlapping gastrointestinal symptoms, and possible pelvic-floor injury during assessment.
• Initial care includes lifestyle modification and conventional laxatives, with response assessed within four weeks.
• Anorectal physiologic testing and biofeedback are highlighted for functional defecatory disorders; surgery is reserved for selected patients after comprehensive evaluation.

Nursing implications

• Document the patient's usual bowel pattern, current symptoms, intake, mobility, medications, prior therapies, and response. Reinforce the prescribed plan and arrange reassessment rather than independently escalating laxatives or assuming all constipation has the same mechanism.

Limitations & cautions

• This is a regional consensus tailored to Asian healthcare settings and resource availability. The PubMed abstract does not provide each statement's evidence certainty, recommendation strength, drug doses, contraindications, or a complete red-flag pathway.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• All 24 included studies were retrospective and most evaluated hospitalized adults using routinely collected structured data.
• Pooled sensitivity was 76.6% and specificity was 84.5%, with a summary ROC area of 0.87.
• At a pooled bloodstream-infection prevalence of 9.5%, positive predictive value was 34.2% and negative predictive value was 97.2%.
• The authors concluded that present accuracy is insufficient to solidly support clinical decision-making.

Nursing implications

• Treat an ML prediction as one data point. Continue the approved sepsis or bloodstream-infection assessment, obtain ordered cultures correctly, and escalate clinical deterioration or discordance between the patient and the model rather than allowing the score to replace judgment.

Limitations & cautions

• The evidence was retrospective, model architectures and populations varied, and heterogeneity was substantial at I2 of 74%. Predictive values depend on infection prevalence, and the abstract does not establish that using these models improves outcomes or antibiotic stewardship.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The registry included 153 pregnancies from 27 Italian multiple-sclerosis centers; 77.1% followed ocrelizumab treatment.
• Overall outcomes included 80.4% live births and 13.1% spontaneous abortions, with no stillbirths or neonatal deaths reported.
• Spontaneous abortion occurred in 20.6% of pregnancies classified as exposed and 7.1% classified as not exposed by drug-specific timing windows.
• Disease activity was generally controlled, but the observational data do not establish comparative pregnancy safety.

Nursing implications

• Reconcile the exact anti-CD20 agent and last administration date, pregnancy timing, disease activity, infection history, and planned maternal and infant follow-up. Promptly communicate new neurologic, obstetric, or infection concerns through the coordinated care plan.

Limitations & cautions

• This observational registry had no untreated concurrent control, small numbers of rare safety events, and drug-specific exposure windows. Most pregnancies involved ocrelizumab, and comparison with general-population rates was contextual; the study cannot prove safety or causation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The post hoc analysis included 264 women from a randomized trial of app-based symptom and adherence monitoring.
• Higher baseline symptom-management self-efficacy was associated with lower symptom burden and greater odds of endocrine-therapy adherence.
• The tailored-feedback intervention showed its largest estimated adherence benefit at lower self-efficacy levels.
• The low-self-efficacy estimate had a wide confidence interval, and effects diminished and became nonsignificant at higher self-efficacy levels.

Nursing implications

• Ask how confident the patient feels managing symptoms and the daily regimen, then assess barriers, symptom burden, missed doses, and support preferences. Route concerns through the survivorship or oncology pathway and use remote monitoring only within the approved program.

Limitations & cautions

• This was a post hoc effect-modification analysis rather than a prespecified primary comparison. Adherence was recorded with a connected pillbox, the low-self-efficacy estimate was imprecise, and the findings do not establish that the same intervention will work in other populations or platforms.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included five randomized trials with 410 participants with cystic fibrosis and respiratory MRSA.
• One small trial suggested more negative respiratory cultures at one month with active oral treatment, but sustained eradication was not established at longer follow-up.
• Nebulized vancomycin reduced MRSA colony counts in one trial, while most lung-function and exacerbation outcomes showed little or no difference.
• The review concluded that available evidence does not demonstrate the effectiveness of routine respiratory MRSA eradication treatment in cystic fibrosis.

Nursing implications

• Obtain and handle respiratory cultures according to the cystic-fibrosis pathway, verify every drug and decontamination component of an ordered eradication regimen, and monitor tolerance and follow-up culture results. Do not start, stop, or extend MRSA treatment based on this review alone.

Limitations & cautions

• Only five trials were included, several were small or had substantial attrition, interventions and outcome definitions differed, and certainty ranged from high to very low. Long-term effects on lung function, mortality, and cost remain unclear.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The meta-analysis included 13 randomized trials with 454 people with multiple sclerosis.
• Vestibular rehabilitation may improve balance, walking speed, walking endurance, and dizziness compared with control interventions.
• Pooled estimates also favored rehabilitation for fatigue and depression measures.
• Transfer ability, balance self-efficacy, and quality of life did not show significant between-group differences.

Nursing implications

• Assess dizziness, gait, transfer safety, fatigue, and recent falls; use the ordered mobility plan and assistive devices; and communicate persistent vestibular symptoms for rehabilitation evaluation. Reinforce the prescribed home program only after confirming technique and safety precautions.

Limitations & cautions

• The pooled evidence came from 13 small trials, comparator interventions varied, and certainty was generally low or very low. The abstract does not establish a single optimal rehabilitation protocol or sustained benefit after treatment ends.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The workflow linked the patient wristband, insulin pen manufacturer barcode, and pharmacy-applied patient label before dispensing.
• The implementation also used two-nurse verification, visual aids, training, support, and a performance dashboard.
• Among 174 nurses surveyed, 67% reported improved patient safety and 71% found the system user friendly.
• The report tracked scan performance and nurse perceptions but did not report a comparative reduction in medication errors or blood-borne pathogen exposures.

Nursing implications

• Scan every required identifier in sequence, pause when the system reports a mismatch, and use the facility escalation path rather than bypassing patient-specific insulin pen controls. Escalate missing labels, unavailable scanners, or workflow workarounds so the safety system can be corrected rather than normalized around.

Limitations & cautions

• This was a single implementation report with four months of process data and a postimplementation nurse survey. Multiple interventions were introduced together, and the abstract did not report medication-error rates, pathogen exposures, a comparison group, or long-term sustainability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The study analyzed 916,904 acute-care visits among 372,140 adults across four Chicago health systems.
• Thirty-three clinically reportable diagnoses remained associated with extreme heat after the two-stage analysis.
• Associated categories included fluid-balance and renal disorders, dermatologic and pressure-related conditions, multiple sclerosis, and several injuries and external causes.
• The observed associations covered the day of heat exposure through the following three days and do not by themselves prove heat caused each diagnosis.

Nursing implications

• During and after extreme heat, ask about exposure, cooling access, hydration, medications, mobility, and symptom timing. Pair temperature and volume-status assessment with the presenting complaint, and escalate instability, altered mentation, severe hyperthermia, or organ dysfunction immediately.

Limitations & cautions

• This observational study used diagnosis codes and data from four Chicago health systems, so coding, local climate, and population differences limit generalizability. Associations cannot establish causation, and the abstract does not provide effect estimates for each retained diagnosis.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The living review included 80 completed randomized trials representing 29,861 participants.
• High-certainty evidence showed higher quit rates with nicotine e-cigarettes than with nicotine replacement therapy.
• The estimated absolute difference was about four additional quitters per 100 people compared with nicotine replacement therapy.
• Trials tested regulated nicotine products; the findings do not apply to illicit products, THC products, or establish long-term safety.

Nursing implications

• Document combustible-tobacco and vaping use separately, assess readiness to quit, and offer the organization's approved counseling and medication pathway. Explain that the evidence concerns regulated nicotine products and does not mean vaping is risk free.

Limitations & cautions

• Only 12 included studies were rated at low overall risk of bias, some safety comparisons were imprecise, and longer and larger trials are needed. Results do not apply to illicit products or products containing other active substances such as THC.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Seven studies included 14,884 patients with recent ischemic stroke, nonvalvular atrial fibrillation, and large-artery atherosclerosis.
• Combined anticoagulant and antiplatelet therapy did not significantly reduce recurrent ischemic stroke versus anticoagulation alone.
• All-cause mortality was not significantly different between strategies.
• Major bleeding was higher with combined therapy (RR 1.49, 95% CI 1.04 to 2.15).

Nursing implications

• During medication reconciliation, identify concurrent anticoagulant and antiplatelet therapy, verify the documented indication and duration, assess for bleeding, and escalate discrepancies or new bleeding promptly. Do not independently stop either drug.

Limitations & cautions

• The meta-analysis combined randomized and observational evidence, so residual confounding and differences among studies remain possible. It addresses a specific population with stroke, atrial fibrillation, and large-artery atherosclerosis and does not cover every indication for combined therapy.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The target-trial emulation included 28,920 veterans with influenza diagnosed in Veterans Health Administration emergency departments.
• Oseltamivir treatment within six hours of a positive test was associated with lower 10-day hospitalization risk.
• ICU admission was also less frequent in the treated group, while 30-day mortality was similar.
• The largest absolute hospitalization-risk reductions were observed in adults aged 65 years or older and when treatment was prescribed within three hours of diagnosis.

Nursing implications

• For a patient with confirmed influenza, communicate the result promptly, complete ordered antiviral screening and administration without avoidable delay, and reinforce dosing and return precautions. Escalate respiratory compromise or other signs of severe illness immediately.

Limitations & cautions

• This was an observational target-trial emulation rather than a randomized trial, so residual confounding is possible. The cohort was predominantly male and drawn from the Veterans Health Administration, limiting generalizability; mortality did not differ between groups.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included nine randomized trials involving 4,814 women in induced or augmented active labor.
• Discontinuation may make little or no difference to cesarean birth and did not meaningfully change instrumental birth risk.
• Stopping oxytocin may reduce uterine hyperstimulation, although the evidence was low certainty.
• Neonatal-unit admission and acidotic cord-gas outcomes showed little or no difference between strategies.

Nursing implications

• Confirm the ordered oxytocin plan and active-labor criteria, monitor uterine activity and fetal heart rate, and respond to tachysystole or abnormal tracing through the unit pathway. Do not stop or continue the infusion based on this review alone.

Limitations & cautions

• Risk of bias varied, 10 potentially eligible studies remained awaiting classification, and certainty ranged from high to low. Evidence for longer active labor was very low certainty, and the review does not define an individualized oxytocin order.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The double-blind trial included 779 eligible adults across 21 Danish hospitals.
• Sustained return of spontaneous circulation was 39% with bicarbonate and 37% with placebo, a nonsignificant difference.
• The trial did not show significant differences in 30-day survival or favorable neurologic outcome.
• Post-arrest alkalosis and hypernatremia were more common in the bicarbonate group.

Nursing implications

• During a code, use sodium bicarbonate only within the approved resuscitation algorithm or a specific clinical indication and order. After administration, communicate the dose and timing and monitor ordered acid-base and sodium results during post-arrest care.

Limitations & cautions

• The primary analysis excluded randomized patients later found ineligible, and the trial enrolled adults who had received at least one epinephrine dose in Danish hospitals. Confidence intervals for survival outcomes were wide, so the study does not exclude smaller benefits or harms in specific indications.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 698 patients with active cancer and suspected acute pulmonary embolism.
• A YEARS strategy using clinical items, D-dimer, and risk-dependent CTPA met the prespecified noninferiority criterion.
• The YEARS pathway avoided immediate CTPA in 77 of 352 patients, or 22%.
• The proportion of negative CTPA results did not differ significantly between groups.

Nursing implications

• Recognize and escalate possible PE promptly, collect the clinical information and ordered D-dimer needed for the approved pathway, and verify whether the organization permits YEARS in active cancer. Do not use the trial to independently rule out PE or defer imaging outside protocol.

Limitations & cautions

• The study was open label, applied a prespecified noninferiority margin, and was conducted in 21 European hospitals. The result supports the tested pathway in eligible patients but does not validate unsupervised bedside use or every cancer population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 18 studies and 7,715 adults with BMI of at least 25 kg/m².
• Three of five sleep-restriction studies found impaired insulin sensitivity or glucose regulation; two did not.
• Poor sleep quality was associated with adverse cardiometabolic outcomes, while fasting-glucose findings were inconsistent.
• The mixed designs and results do not define a specific sleep intervention for glycemic control.

Nursing implications

• Ask about sleep duration, quality, and barriers during cardiometabolic assessment and discharge teaching. Document persistent sleep concerns and route them for evaluation while reinforcing the prescribed glucose-monitoring, medication, nutrition, and activity plan.

Limitations & cautions

• The 18 studies mixed crossover, cross-sectional, controlled, and cohort designs; sleep measures and interventions differed. Results for sleep restriction and fasting glucose were inconsistent, so causality and the best sleep intervention remain uncertain.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review pooled 19 randomized trials with 1,527 breast cancer surgery patients.
• Postoperative morphine use and pain scores were comparable between the two regional-block techniques.
• Postoperative nausea and vomiting, fentanyl use, rescue analgesia, and analgesia duration were also comparable.
• The findings do not establish that one block is superior for postoperative analgesia.

Nursing implications

• Identify which block the patient received, trend pain at rest and with movement, document rescue analgesia and nausea, and escalate inadequate control or unexpected deterioration through the perioperative team’s pathway.

Limitations & cautions

• The abstract reports pooled comparisons but does not describe heterogeneity, certainty of evidence, or complication rates in detail. Choice of block remains a procedural decision based on patient factors, clinician expertise, and local practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Vaccination status should be reviewed and updated before transplant and when travel is planned.
• Post-transplant vaccination requires attention to timing and the patient's transplant-specific clinical context.
• The update covers COVID-19 and RSV vaccines plus newer pneumococcal, meningococcal, hepatitis B, and recombinant zoster formulations or indications.
• Safe-living counseling also includes travel, food, water, pets, sexual activity, and vaccination of close contacts.

Nursing implications

• Reconcile the patient's vaccination history, document transplant status and travel plans, and route gaps or timing questions to the transplant or infectious-disease team. Reinforce the team's approved safe-living education and avoid independently administering live vaccines after transplant.

Limitations & cautions

• The accessible abstract summarizes the guideline's scope but does not provide every vaccine-specific schedule, contraindication, or recommendation grade. Patient age, organ type, immunosuppression, timing, and local epidemiology require individualized transplant-team decisions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 170 adults with multivessel coronary disease who were eligible for both surgical approaches.
• One-month patient-reported physical recovery favored small-thoracotomy CABG by 2.9 SF-36 physical-component points.
• No deaths or strokes occurred in either group through 12 months; one major cardiac or cerebrovascular event occurred in the minimally invasive group.
• Results apply to selected patients treated by experienced teams, and the study was funded by Medtronic.

Nursing implications

• Confirm the operative approach during handoff and use its approved incision, mobility, pain, respiratory, and activity pathway. Track functional recovery and escalate unexpected cardiopulmonary, wound, or neurologic findings without assuming the smaller incision removes standard CABG risks.

Limitations & cautions

• The trial was open label, enrolled 170 highly selected patients suitable for either approach, and was performed by experienced teams. It was funded by Medtronic, most participants were men, and uncommon safety outcomes cannot be ruled out from zero events in this sample.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 17 randomized trials with 1,396 participants after intracerebral hemorrhage.
• Pooled neurologic, motor, and activities-of-daily-living scores favored very early rehabilitation over later early rehabilitation.
• Evidence certainty was low for all outcomes and heterogeneity was substantial.
• Safety outcomes such as rebleeding, hemodynamic instability, and falls were inadequately reported for quantitative synthesis.

Nursing implications

• Before each ordered rehabilitation session, verify neurologic and hemodynamic stability and the current mobility level. Monitor symptoms and vital signs during activity, use fall precautions, and stop and escalate for new neurologic change, instability, or other protocol-defined concerns.

Limitations & cautions

• The pooled trials varied in rehabilitation timing and methods, showed substantial heterogeneity, and produced low-certainty evidence. Standardized reporting of rebleeding, hemodynamic instability, and falls was insufficient, so the review cannot define the safest universal start time.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Forty-three randomized trials involving 1,628 people after stroke were included.
• Versus conventional therapy, brain-computer interface training may slightly improve upper-extremity motor function based on low-certainty evidence.
• Effects on activities of daily living were very uncertain, and lower-extremity motor function showed little to no difference in the conventional-therapy comparison.
• Risk of bias, small samples, imprecision, and possible publication bias lowered confidence across comparisons.

Nursing implications

• If brain-computer interface training is part of an ordered rehabilitation program, reinforce the individualized therapy plan and document tolerance, participation, function, and safety concerns. Avoid promising broad motor or daily-function recovery from the technology alone.

Limitations & cautions

• Evidence certainty ranged from low to very low. Many trials had unclear or high risk of bias, sample sizes were small, interventions and comparators varied, and adverse-event and activities-of-daily-living findings remained uncertain.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 16 randomized trials with 6,611 participants treated for at least 12 weeks.
• Compared with placebo, dual GLP-1/glucagon receptor agonists reduced body weight by a pooled 7.44% and 7.27 kg.
• Weight loss was accompanied by improvements across the cardiometabolic risk factors assessed in the review.
• Versus selective GLP-1 receptor agonists, the clearest additional pooled difference reported in the abstract was lower triglycerides by 0.28 mmol/L.

Nursing implications

• When a patient is receiving a prescribed incretin-based therapy, document the exact agent and indication and follow the approved pathway for weight, glycemic, hemodynamic, laboratory, and adverse-effect monitoring. Do not treat pooled changes in risk markers as proof of fewer cardiovascular events.

Limitations & cautions

• The abstract reports risk-factor outcomes rather than cardiovascular events, mortality, or long-term safety. Trials varied by dose and indication, and the authors call for large-scale outcome studies before broader conclusions about clinical benefit.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Both randomized diet groups improved during the initial six-week intervention.
• Personalized-diet symptom improvement was maintained at six and 12 months, while low-FODMAP benefits regressed by 12 months.
• At 12 months, IBS symptom-score responder rates were 62.5% versus 34.5%, an absolute difference of 28 percentage points.
• The authors describe the follow-up as hypothesis-generating and call for larger trials powered for long-term outcomes.

Nursing implications

• Ask what dietary plan the patient is following, whether symptoms and nutrition are being monitored, and whether a qualified clinician or dietitian is guiding restriction and reintroduction. Avoid presenting commercial microbiome personalization as established standard care on the basis of this follow-up alone.

Limitations & cautions

• This open-label follow-up included participants who completed the initial six-week intervention, and the abstract does not report the randomized sample size. No further dietary intervention was delivered during follow-up, and the authors characterize the results as hypothesis-generating.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The analysis included 550 patients from the BRIDGE-TNK trial, with 241 in the ASPECTS-below-8 subgroup and 309 in the ASPECTS-8-to-10 subgroup.
• In the lower-ASPECTS subgroup, functional independence was more frequent with tenecteplase plus thrombectomy than with thrombectomy alone.
• No functional improvement was detected in the higher-ASPECTS subgroup, where the mortality signal raised a possible safety concern.
• The authors explicitly require prospective randomized confirmation before changing practice.

Nursing implications

• Continue using the approved acute-stroke eligibility and medication pathway without independently applying this ASPECTS subgroup finding. Record treatment times, neurologic assessments, blood pressure, and bleeding concerns precisely and escalate changes immediately.

Limitations & cautions

• This was an exploratory post hoc subgroup analysis of a trial conducted in China, not a prospectively powered comparison by ASPECTS. Subgroup signals can be unstable, and the higher-ASPECTS mortality finding requires confirmation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The population-based cohort included 9,066 community-dwelling adults with a mean age of 53.3 years.
• Over a mean 7.8 years, 23.1% had at least one hospital admission and 12.1% of those admitted had a readmission.
• MMSE-defined cognitive impairment was associated with a 40% higher hospital-admission rate, but readmission rates did not differ.
• Results varied by screening instrument, and chronic conditions and overall disease burden may be more important drivers of hospital use.

Nursing implications

• At admission and discharge, identify documented cognitive or communication needs, assess the support available for medication and follow-up tasks, and use teach-back with the patient and caregiver when appropriate. Pair cognitive findings with chronic-disease and functional assessment rather than using a screening score alone.

Limitations & cautions

• This observational cohort cannot establish that cognitive impairment causes hospitalization. Results differed between the MMSE and ACE-R, the cohort was from one region of Chile, and participants were ages 38 to 74 rather than an exclusively geriatric population.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Nineteen longitudinal studies involving 132,054 adults with alcohol-associated liver disease met inclusion criteria.
• Diabetes was consistently associated with overall mortality, liver-related mortality, hepatocellular carcinoma, and cardiovascular mortality.
• Elevated BMI and metabolic syndrome were also associated with several adverse hepatic and cardiovascular outcomes.
• A greater cardiometabolic risk-factor burden correlated with lower transplant-free survival and less hepatic recompensation.

Nursing implications

• Include cardiometabolic conditions and relevant monitoring in the whole-patient assessment rather than focusing only on alcohol exposure and hepatic findings. Reinforce the established follow-up plan for liver disease, diabetes, nutrition, cardiovascular risk, and alcohol-use treatment when ordered.

Limitations & cautions

• The review synthesized observational associations with varied estimates and cannot establish causation or a specific treatment effect. It also included recent conference abstracts alongside peer-reviewed studies, and the abstract does not provide a pooled certainty rating.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included one New Zealand randomized trial involving 132 infants born at 34 0/7 to 36 6/7 weeks' gestation.
• Caffeine may reduce intermittent hypoxemia episodes over one week, but this finding was based on low-certainty evidence.
• Effects on respiratory support, length of stay, and treatment-stopping adverse effects remained very uncertain.
• No study reported major neurodevelopmental disability or evaluated methylxanthines for treatment of established hypoxemia, apnea, or respiratory insufficiency.

Nursing implications

• When caring for a late-preterm infant receiving a prescribed methylxanthine, confirm the documented indication and follow the ordered cardiorespiratory surveillance and medication-monitoring pathway. Record hypoxemia or apnea events consistently so the team can evaluate response without assuming benefit beyond the limited evidence.

Limitations & cautions

• All conclusions came from one 132-infant trial. Every outcome was downgraded for serious or very serious imprecision, several outcomes also had risk-of-bias concerns, and no evidence addressed treatment of established respiratory problems or major neurodevelopmental disability.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 10 controlled studies of follow-up after an abnormal FIT or fecal occult blood test in health-disparity populations.
• Eight studies evaluated patient navigation, which increased colonoscopy completion versus usual care with a pooled risk ratio of 1.27.
• The navigation result was rated moderate certainty and remained stable across the review's registered pooled analyses.
• Evidence for registry-based quality improvement and low-touch result notification came from one study each.

Nursing implications

• At result communication or transition of care, verify that the patient understands the need for diagnostic colonoscopy, who will arrange it, and how preparation or transportation barriers will be addressed. Track open referrals according to the organization's follow-up process rather than treating an abnormal screening result as a closed task.

Limitations & cautions

• Interventions and follow-up intervals varied, relatively few studies informed each intervention type, and detection data were sparse. The review supports navigation for completion, but it does not identify one universally effective navigation model or establish effects on cancer stage or mortality.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The double-blind trial enrolled 955 adults across 33 hospitals in 10 countries before elective cardiac surgery.
• Participants received 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
• In-hospital red-cell transfusion was less frequent with intravenous iron, with a relative risk of 0.90.
• The adjusted improvement in days alive and at home was one day, with no detected difference in major complications or hospital length of stay.

Nursing implications

• For a patient enrolled in a preoperative anemia pathway, verify the ordered iron formulation, dose, timing, required laboratory data, and infusion-monitoring steps. Continue standard postoperative bleeding and transfusion surveillance; preoperative treatment does not eliminate the need for individualized blood-management decisions.

Limitations & cautions

• The primary outcome difference was small, transfusion remained common in both groups, and the trial found no difference in major complications or hospital stay. Results apply to anemic adults undergoing elective cardiac surgery and do not establish benefit for emergency surgery or patients meeting the trial's exclusions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The review included 11 randomized trials and 750 pediatric patients; six studies informed the pain network and five informed the complication network.
• Neither penile block nor pudendal nerve block significantly improved 24-hour pain compared with caudal block.
• No significant complication-rate differences were identified among caudal block, penile block, and general anesthesia.
• Treatment rankings describe probabilities and should not be interpreted as proof that one technique is clinically superior.

Nursing implications

• Use the age-appropriate pain scale and recovery-monitoring schedule required by the service, document rescue analgesia and adverse findings, and escalate inadequate pain control or unexpected motor, sensory, urinary, or hemodynamic changes. Treat block selection as an anesthesia-team decision rather than a nursing inference from rankings.

Limitations & cautions

• The pain network had substantial heterogeneity and low certainty because of imprecision and incoherence. The abstract reports moderate-certainty complication evidence but does not establish equivalence among techniques or address every clinically relevant adverse event.
• AI-summarized from the linked source. Review the original article before applying to practice.